Trials / Completed
CompletedNCT01824017
Validation of an RLIP76 Assay in Humans
Validation of RLIP76 Assay and Exploratory Study of RLIP76 Correlation Among Patients With Type 2 Diabetes and Metabolic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- City of Hope Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current proposal extends work done in mouse models evaluating the consistency of measuring RLIP76 in a clinical cohort (Aim 1) by using guidelines provided by the NIH for validating biomarkers. We will also proceed to estimate the effect size of a potential correlation of RLIP76 with standard MsY treatment measures such as hgbA1c, LDL, and triglyceride levels in a longitudinal prospective study ( Aim 2) that will follow a cohort of patients with MsY who seek care at the City of Hope Endocrine clinic over a 12 month period..
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Draw |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2013-04-04
- Last updated
- 2016-09-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01824017. Inclusion in this directory is not an endorsement.